Invention Grant
- Patent Title: Chelate compounds
-
Application No.: US16311564Application Date: 2017-06-20
-
Publication No.: US11884686B2Publication Date: 2024-01-30
- Inventor: Andreas Richard Meijer , Mikkel Jacob Thaning , Brian Christopher Bales , Michael James Rishel
- Applicant: GE HEALTHCARE AS
- Applicant Address: NO Oslo
- Assignee: GE HEALTHCARE AS
- Current Assignee: GE HEALTHCARE AS
- Current Assignee Address: NO Oslo
- Agency: Goodwin Procter LLP
- Priority: GB 10738 2016.06.20
- International Application: PCT/EP2017/065135 2017.06.20
- International Announcement: WO2017/220610A 2017.12.28
- Date entered country: 2018-12-19
- Main IPC: C07F13/00
- IPC: C07F13/00 ; C07D471/08
Abstract:
The invention provides compounds suitable for use as contrast agents in magnetic resonance imaging (MRI). The compounds of the present invention are manganese (II) complexes having advantageous properties as compared with similar known compounds.
Public/Granted literature
- US20190233450A1 CHELATE COMPOUNDS Public/Granted day:2019-08-01
Information query
